The emerging role of targeting cancer metabolism for cancer therapy

  title={The emerging role of targeting cancer metabolism for cancer therapy},
  author={Pegah Farhadi and Reza Yarani and Sadat Dokaneheifard and Kamran Mansouri},
  journal={Tumor Biology},
Glucose, as the main consuming nutrient of the body, faces different destinies in cancer cells. Glycolysis, oxidative phosphorylation, and pentose phosphate pathways produce different glucose-derived metabolites and thus affect cells’ bioenergetics differently. Tumor cells’ dependency to aerobic glycolysis and other cancer-specific metabolism changes are known as the cancer hallmarks, distinct cancer cells from normal cells. Therefore, these tumor-specific characteristics receive the limelight… 

Figures from this paper

1-C Metabolism—Serine, Glycine, Folates—In Acute Myeloid Leukemia

Recent studies have shown that in response to glutamine deprivation leukemia cells upregulate key enzymes in the serine biosynthesis pathway, suggesting that serine upregulation may be a targetable compensatory mechanism.

Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases

It is proposed that melatonin’s function as a glycolytic explains its actions in inhibiting a variety of diseases and the common denominator is melatonin's action in switching the metabolic phenotype of cells.

Butyrate and Metformin Affect Energy Metabolism Independently of the Metabolic Phenotype in the Tumor Therapy Model

The BALB-TTM is a relevant model for mechanistic cancer research, and the generation of monoclonal cell lines offers a novel possibility to investigate specific drug effects in a heterogeneous tumor cell population, as well as indicating that induced alterations in energy metabolism seem to be independent of the original metabolic phenotype.

Connexins and Glucose Metabolism in Cancer

Significant progress has been made in understanding of connexin and cancer biology, however, delineating the roles these multi-faceted proteins play in metabolic adaptation of cancer cells is just beginning.

Quercetin acts via the G3BP1/YWHAZ axis to inhibit glycolysis and proliferation in oral squamous cell carcinoma.

Quercetin can inhibit glycolysis and cell proliferation of oral squamous cell carcinoma, apparently by inhibiting the G3BP1/YWHAZ axis.

Sphingolipid metabolism is associated with osteosarcoma metastasis and prognosis: Evidence from interaction analysis

It is shown that sphingolipid metabolism is associated with osteosarcoma metastasis and prognosis, which has the potential to be a therapeutic target for OS.

Emerging Role of TCA Cycle-Related Enzymes in Human Diseases

This review aims to provide a comprehensive overview of the relationship between each TCA cycle-related enzyme and human diseases, and discusses their functions in the context of both mitochondrial and extra-mitochondrial enzymes.

miR-183-5p Promotes HCC Migration/Invasion via Increasing Aerobic Glycolysis

Findings suggest that miR-183-5p may promote HCC migration and invasion via increasing aerobic glycolysis through targeting PTEN and then activating Akt/mTOR signaling.



The Pentose Phosphate Pathway as a Potential Target for Cancer Therapy

The role of Snail (Snai1), an important regulator of the epithelial mesenchymal transition (EMT), in controlling glucose flux towards PPP and thus potentiating cancer cell survival under oxidative and metabolic stress is summarized.

Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?

Inhibition of PDKs could be an attractive therapeutic approach for the development of anti-cancer drugs because of their role as regulator of PDC that catalyzes the oxidative decarboxylation of pyruvate in mitochondrion.

Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer

Recent advances in the development of chemotherapeutic agents against several metabolic targets for cancer therapy are covered, including glucose transporters, hexokinase, pyruvate kinase M2, glutaminase, and isocitrate dehydrogenase.

Oxidative Phosphorylation as an Emerging Target in Cancer Therapy

Novel applications of OXPHOS inhibitors with a suitable therapeutic index to target cancer cell metabolism are highlighted and several drugs including metformin, atovaquone, and arsenic trioxide are used clinically for non-oncologic indications, but emerging data demonstrate their potential use as OXPI inhibitors.

Cancer metabolism: a therapeutic perspective

How cancer cells reprogramme their metabolism and that of other cells within the tumour microenvironment in order to survive and propagate, thus driving disease progression is discussed; in particular, potential metabolic vulnerabilities that might be targeted therapeutically are highlighted.

Monocarboxylate transporters in cancer

Regulation of the pentose phosphate pathway in cancer

A better understanding of how the PPP is reprogrammed and the mechanism underlying the balance between glycolysis and PPP flux in cancer will be valuable in developing therapeutic strategies targeting this pathway.

Defining the molecular basis of tumor metabolism: a continuing challenge since Warburg's discovery.

T tumor metabolism is still only partly understood and the metabolic aspects of transformation constitute a major challenge for science, Nevertheless, cancer metabolism can be exploited to devise novel avenues for the rational treatment of this disease.